Terrence Bradley
@TBradley_MD
Clinical Researcher in MDS/AML/MPN; Leukemia Program @SylvesterCancer ; Assistant Professor of Medicine @UnivMiami
We have an APL patient, unfortunately uninsured/undocumented, will return to Colombia for consolidation therapy. Please let me know if any reccs for hematologists in Bogota/Cartagena! Appreciate help #leusm @MikkaelSekeres @GlopesMd
Our new paper is out @Nature_NPJ Precision Oncology! rdcu.be/eujnK With @JustinWattsMD and colleagues @SylvesterCancer we report on the first patient functionally cured by single-agent IDH1 inhibition with Olutasidenib @RigelPharma for r/r #AML @NaturePortfolio 🧵
Congratulations to Dr. Justin Taylor on receiving a prestigious Stanley J. Glaser Foundation Research Award to advance his work on a potential new approach to treating colorectal cancer. 🙌 The study reveals how targeting the XPO1 gene mutation with selinexor, combined with…
Please RT and help us make it to the semifinals #STATMadness! @GlopesMd @Latinamd @DrTracyECrane @JTrentMDPhD @DrSDNimer @MikkaelSekeres @KenFigueroaLab @HemOncMiami @SylvesterCancer @umiamimedicine @univmiami @UMiamiHealth
This is very cool! Please vote for us @umiamimedicine @univmiami in #STATMadness 2025! Get your vote in today before the round ends statnews.com/feature/stat-m… @SylvesterCancer #CancerResearch #Cancer #CLLsm #leusm #lymsm #MarchMadness #Miami
We made it to round 2! Thanks to everyone who shared. Please help get out the vote for the round happening this week- 32 teams/Universities left #STATMadness statnews.com/feature/stat-m… @CarmenCalfa @DrOlaLandgren @KenFigueroaLab @SylvesterCancer @umiamimedicine @univmiami
Cast your vote #STATMadness now! @statnews #MarchMadness equivalent for #Science Please RT & spread the word! @GlopesMd @JTrentMDPhD @Latinamd @MikkaelSekeres @DrSDNimer @NimaSharifiMD @DrTracyECrane @AshishHShah4 @SylvesterCancer @umiamimedicine @univmiami #Miami @TackleCancer
Cast your vote #STATMadness now! @statnews #MarchMadness equivalent for #Science Please RT & spread the word! @GlopesMd @JTrentMDPhD @Latinamd @MikkaelSekeres @DrSDNimer @NimaSharifiMD @DrTracyECrane @AshishHShah4 @SylvesterCancer @umiamimedicine @univmiami #Miami @TackleCancer
This #ASH24 presentation is a must watch, check it out on the virtual platform if you missed it in person. @SylvesterCancer @CUSystem @DanPollyea @JustinWattsMD @MikkaelSekeres @drsangeetmd @TBradley_MD @NamrataChandhok @TaylorJ_MD
CONGRESS | #ASH24 | PRESENTATION @DanPollyea, @CUSystem, discussed findings from a prospective, single-arm, phase II trial (NCT03573024) of venetoclax + azacitidine in patients with newly diagnosed AML. The study was stopped at Stage 3 (n=27) as the ORR (67%) did not meet the…
Today is #WorldCancerResearchDay. 🧬🔬 As South Florida's only NCI-designated cancer center, we’re advancing #CancerResearch with the new Kenneth C. Griffin Cancer Research Building, which will bring hope to South Florida and beyond. Learn more: loom.ly/lok8m7E
47 yrs ago my father took care of a young woman with TTP, and the management of this disease with nearly 💯% fatality rate changed forever, saving countless lives. Check out this segment highlighting what an incredible physician he is: cbsnews.com/miami/video/wo…
Proud of this team. #oneteamonefight @MiamiDolphins @TackleCancer.
We are proud to announce (thank you @serenawilliams!) that we have partnered with @TackleCancer and @SylvesterCancer to raise $30M in 10 years for cancer research!
Congratulation to these excellent scientists! In particular Marcella Kaddoura for her super project on Venetoclax resistance in multiple myeloma #mmsm
Kudos to rising ⭐️@GretelTerrero on her @SylvesterCancer #K12 @univmiami Calabresi Clinical Oncology Research Career Development Program award, studying #ctDNA guided therapy in #Pancsm #SPCRI
Our article is out in @Bloodneoplasia VEN/HMA in Octogenarians with AML ashpublications.org/bloodneoplasia…
Congrats to you both! Excellent job!
Congratulations to Dr. Sana Chaudhry on a successful dissertation defense today! And paper just accepted last week! Thankful to her committee members @SylvesterCancer (tagged below) and external member Josean Rodriguez @upvehu! And all our lab members and collaborators! #ProudPI
How do pts w/ MPN-AP/BP fare in the current era of AML therapies? Check out our multi-center analysis of 202 pt in @BloodAdvances focused on this question! #mpnsm #leusm Thanks to mentor @myeloidmalig for her guidance - follow the thread for a deep dive! ashpublications.org/bloodadvances/…
We proved tx 80-90yo with AML can be done (dose reduction 🗝️) Check out our multisite analysis of ven hma in octo and nona generians. Thankful for this collab! @SylvesterCancer @JustinWattsMD sciencedirect.com/science/articl…
Thank you Hide, Adnan and @DrSDNimer for allowing us to contribute to this project! Nice to see it out now @NatureComms #leusm #MPNsm @SylvesterCancer rdcu.be/dFwoy
Fantastic talk and visit from @DrChrisHourigan! Resounding response from our @SylvesterCancer trainees and faculty! @GlopesMd @DrOlaLandgren @JustinWattsMD @drsangeetmd @TBradley_MD @MikkaelSekeres P.S. He’s hiring @FralinBiomed @virginia_tech
Thank you for the great talk on MRD in AML @DrChrisHourigan 🤩 waiting for great things ahead ! @DrOlaLandgren @SylvesterCancer
Potential Underlying Genetic Mutations Identified in Patients With Myelodysplastic Syndromes - Thanks to the @ASCOPost for highlighting our research! #MDSsm #leusm ascopost.com/news/december-…
Weekend rounds starting off with a morning quarrel @SylvesterCancer
Excited to present this evening my @lymphoma clinical investigator career development award in R/R follicular lymphoma now transitioning to a multicenter study. @SylvesterCancer @umiamimedicine #ASH23